Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 21, 2023 10:34 PM 3 min read

Investing In Cannabis In 2024? BDSA Analyst Signals Key Markets And Profitable Growth Segments

by Nicolás Jose Rodriguez Benzinga Staff Writer
Follow

BDSA's analyst Brendan Michel-Chesebro sheds light on the potential of cannabis products on the U.S. cannabis market, highlighting the significant opportunities and risks for 2024.

Opportunities and Risks in Hemp Products

Hemp-derived products, unlike their cannabis counterparts, are not bogged down by heavy taxation and stringent regulations.

This grants them lower operational costs, higher margins, and broader distribution possibilities.

Particularly, the entry of these products into liquor and grocery stores, and their collaboration with major beverage and alcohol distributors, signals a major shift.

Ramp Up In Hemp-Derived Cannabis Beverages

Michel-Chesebro emphasizes the beverage sector as a particularly promising area, given the logistical challenges cannabis retailers face with beverages, such as distribution costs and the need for refrigeration.

However, there are risks involved, primarily concerning consumer safety due to less rigorous testing compared to legal cannabis products.

BDSA's analyst suggests that the entrance of reputable CPG brands into the hemp-derived product space could standardize industry practices and mitigate these risks.

Struggles And Potential Of New York's Cannabis Market

Despite high hopes for the rapid launch of more retailers in 2023, progress has been slower than anticipated in New York.

This sluggishness in opening new dispensaries has hindered the market's ability to compete effectively with the well-established illicit market.

The state's enforcement efforts against unlicensed dispensaries have only recently begun to show results, but more needs to be done to truly impact the illicit market.

Michel-Chesebro suggested increasing retail availability and lowering legal market prices are key strategies for mitigating these issues. However, these efforts are expected to continue facing challenges throughout 2024.

Consumer Trends And Product Preferences In 2024

Looking at consumer trends, Michel-Chesebro predicts the continued strength of infused pre-roll sales and growth in the disposable vape category. He cites a 58% growth in disposable vape SKUs in California between 2021 and 2023 as evidence of the category's burgeoning popularity.

Innovation in this space, such as dual-chamber vapes and improved reliability, has attracted a broader consumer base. Furthermore, premium options within disposable vapes have seen significant growth, catering to consumers who prioritize quality and flavor.

The Economic Logic Of Proprietary Strains

2024 will present the challenges and benefits of developing proprietary strains. While it's a costly and lengthy process, unique strains can help brands stand out and avoid the "race to the bottom" in chasing popular strains.

These proprietary strains often command higher prices – in California, for instance, single-brand strains were priced 34% higher on average than the market average for flowers. This approach can be a powerful differentiator in an increasingly competitive market.

Budget-Friendly Products

Michel-Chesebro also discussed the importance of budget-friendly products like Trim and Shake in price-sensitive markets.

Even though these categories represent a small share of total sales, they hold significant potential, especially in newly launched markets facing supply shortages and high prices.

He notes that low price is the third most commonly cited driver of product choice among consumers, indicating a substantial market for affordable cannabis products.

As more states move towards legalization, these budget-friendly options could play a crucial role in balancing consumer demand and affordability.

Photo by BoliviaInteligente on Unsplash. 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Analyst ColorCannabisNewsExclusivesMarketsInterviewBDSAHemp
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...